Key Record Dates
ClinicalTrials.gov Identifier: | NCT05915442 |
---|---|
Brief Title: | Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer (SBRT-AMICO) |
First Submitted : | June 7, 2023 |
First Submitted that Met QC Criteria : | June 14, 2023 |
First Posted : | June 23, 2023 |
Last Update Submitted that Met QC Criteria : | May 6, 2024 |
Last Update Posted : | May 7, 2024 |